期刊文献+

1056例皮下埋植避孕剂取出原因分析 被引量:6

Analysis of the Reasons of Norplant Removal in 1056 Cases
下载PDF
导出
摘要 目的:探讨皮下埋植避孕剂取出原因与取出年龄和放置时间的关系。方法:对1994年1月—2014年12月在本所门诊取出皮下埋植避孕剂的1 056例育龄妇女进行取出原因分析,比较不同取出年龄段及不同放置时间的因症取出原因的构成比。结果:1 056例皮下埋植避孕剂取出人群中,539例期满取出,395例因月经异常取出,97例因除月经外其他不适取出,23例因计划妊娠或改用其他避孕方法取出,2例在有效期内避孕失败取出。皮下埋植避孕剂取出原因构成比在不同取出年龄组中差异有统计学意义(P<0.05),在不同放置时间组中差异无统计学意义(P>0.05);其中不同取出年龄和放置时间组中,月经异常和头痛、痤疮等其他症状的构成比差异均有统计学意义(P<0.05),计划妊娠或改用其他避孕方法的构成比差异无统计学意义(P>0.05)。结论:皮下埋植避孕剂是持久、高效、简便的避孕方法,月经异常和头痛、痤疮等症状是不同年龄段和放置时间皮下埋植避孕剂取出的主要原因。 Objective:To explore the relationship between the Norplant removal and the placed age and time. Methods:The reasons for the Norplant removal, and the constituent ratios of the reasons to removed-age and to placed-time, were analyzed in 1 056 cases in our Institution from January 1994 to December 2014.Results: In those 1 056 cases of Norplant removal, 539 cases were due to expiration, 395 cases were due to abnormal uterine bleeding, 97 cases were due to other discomfort beside menstruation, 23 cases were due to planned pregnancy or switch to other contraception, and 2 cases were due to contraceptive failure. The constituent ratio of the removed reasons showed significant difference in the different removed-age groups(P〈0.05), but did not show significant difference in the placed-time groups(P〉0.05). The constituent ratios of abnormal uterine bleeding,headache,acne and other symptoms, showed statistical difference in the removal age and implant time groups( P〈0. 05), while those ratios did not show significant difference in the planned pregnancy or switch to other contraception groups(P〈0.05). Conclusions: Norplant is a long-acting, simple and efficient contraceptive method. The abnormal uterine bleeding, headache, acne and other symptoms are the main reasons of Norplant removal in different age and implant time groups.
出处 《国际生殖健康/计划生育杂志》 CAS 2016年第1期29-31,共3页 Journal of International Reproductive Health/Family Planning
关键词 宫内避孕器 避孕 左炔诺孕酮 月经失调 Intrauterine devices Contraception Levonorgestrel Menstruation disturbances
  • 相关文献

参考文献10

  • 1Feldblum PJ,Hanitrinia ina O,Lendvay A,et al. Performance of Sino-implant (11) in routine service delivery in Madagascar [J]. Contraception,2013,88( 1 ) : 103-108.
  • 2雷贞武,周静.皮下埋植避孕剂出血不良反应及安全性的研究进展[J].国际生殖健康/计划生育杂志,2011,30(6):425-428. 被引量:12
  • 3Lendvay A,Otieno-Masaba R,Azmat SK,et al. Effectiveness, safety and acceptability of Sino-implant (11) during the first year of use: results from Kenya and Pakistan [J]. Contraception,2014,89 (3) : 197-203.
  • 4Short M, Dallay D, Omokanye S, et al. Acceptability of long-acting, progestin-only contraception in Europe: a two-year prospective, non-interventional study[J]. Eur J Contracept Reprod Health Care, 2014,19( 1 ) :29-38.
  • 5Weisberg E,Bateson D,McGeechan K,et al. A three-year comparative study of continuation rates, bleeding patterns and satisfaction in Australian women using a subdermal contraceptive implant or progestogen releasing-intrauterine system [J]. Eur J Contracept Reprod Health Care, 2014,19( 1 ) : 5-14.
  • 6Fraser IS,Critchley HO,Broder M,et al. The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding [J]. Semin Reprod Med, 2011,29 (5) : 383-390.
  • 7Cihangir U, Ebru A, Murat E, et ah Mechanism of action of the levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding [J]. Int J Gynaecol Obstet,2013 , 123 (2) : 146-149.
  • 8沈美文,倪红.40岁以上妇女继续放置皮下埋植剂的临床探讨[J].国际生殖健康/计划生育杂志,2010,29(5):338-339. 被引量:2
  • 9杜娟,雷贞武.单纯孕激素长效避孕剂安全性研究进展[J].实用妇产科杂志,2014,30(7):485-488. 被引量:5
  • 10McDonald-Mosley R, Burke AE. Contraceptive implants[J]. Semin Reprod Med,2010,28(2) : 110-117.

二级参考文献25

  • 1雷贞武,赵铀.女用甾体激素避孕药的临床应用研究进展[J].中国计划生育学杂志,2007,15(2):124-126. 被引量:4
  • 2孙彦荣,王树松,倪焕青,简秀坤,王俊婷,闫梅.米非司酮不同服用方法对皮下埋植术后子宫出血影响的观察[J].中国计划生育学杂志,2007,15(7):425-427. 被引量:7
  • 3Merki-Feld GS, Imthurn B, Seifert B, et al. Effects of the progestagen-only contraceptive implant Implanon on cardiovascular risk factors[J]. Clin Endocrinol (Oxf), 2008,68 (3) : 355-360.
  • 4Pritts EA, Ryan IP,Mueller MD, et al. Angiogenic effects of Norplant contraception on endometrial histology and uterine bleeding[J]. J Clin Endocrinol Metab,2005,90(4):2142-2147.
  • 5Zhao S, Chokuchat C, Zhao Y, et al. Effects of doxycycline on serum and endometrial levels of MMP-2, MMP-9 and TIMP-1 in women using a levonorgestrel-releasing subcutaneous implant [J]. Contraception,2009,79(6) :469--478.
  • 6Archer DF, Philput CB, Levine AS, et al. Effects of ethinyl estradiol and ibuprofen compared to placebo on endometfial bleeding, cervical mucus and the postcoital test in levonorgestrel subcutaneous implant users[J]. Contraceprion,2008,78(2): ! 06-112.
  • 7Massie MR, Pavez M, Fuenteabla B, et al. Effect of intermittent treatment with mifepristone on bleeding patterns in Norplant implant users[J]. Contraception, 2004,70( 1 ) :47-54.
  • 8Weisberg E, Hickey M, Palmer D, et al. A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using implanon[J]. Hum Reprod, 2006,21 ( 1 ) : 295-302.
  • 9Weisberg E, Hickey M, Palmer D, et al. A randomised controlled trial of treatment options for troublesome uterine bleeding in implanon users[J]. Hum Reprod,2009,24( 8 ): 1852-1861.
  • 10d'Arcangues C, Piaggio G, Brache V, et al. Effectiveness and acceptability of vitamin E and low-dose aspirin,alone or in combination, on Norplant-induced prolonged bleeding [J]. Contraception, 2004,70(6) :451-462.

共引文献15

同被引文献41

引证文献6

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部